Case number 1:21-cv-00992
Astellas Pharma Inc. et al v. Alkem Laboratories Ltd. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 26, 2021 | 19 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,342,117; 7,982,049; 8,835,474; 10,842,780; RE44,872. (nmg) |
| Oct 25, 2021 | 18 | Stipulation and Order (2) Docket Text: STIPULATION AND ORDER. CASE CLOSED. Signed by Judge Joseph F. Bataillon on 10/25/2021. (nmg) |
| Oct 20, 2021 | 17 | Stipulation of Dismissal (3) Docket Text: STIPULATION of Dismissal Without Prejudice as to Alkem Laboratories Ltd. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) |
| Oct 1, 2021 | 16 | Stipulation (3) Docket Text: STIPULATION and Proposed Order to Stay All Deadlines Pending Execution of Settlement by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) |
| Oct 1, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. (16 in 1:21-cv-00992-JFB-CJB, 188 in 1:20-cv-01589-JFB-CJB) Stipulation filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. All hearings and deadlines between the Plaintiffs and Alkem are stayed for sixty (60) days, through November 30, 2021. Ordered by Judge Christopher J. Burke on 10/1/2021. Associated Cases: 1:20-cv-01589-JFB-CJB, 1:21-cv-00992-JFB-CJB(dlb) |
| Sep 21, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [15] MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III and Timothy H. Kratz filed by Alkem Laboratories Ltd. Ordered by Judge Christopher J. Burke on 9/21/2021. (dlb) |
| Sep 21, 2021 | N/A | Create Case Association (0) Docket Text: Case associated with lead case 20-1589. All filings concerning the 780 Patent between Plaintiffs and Alkem shall be made only in the Consolidated Action; All claims, defenses, and/or counterclaims concerning the remaining Patents-In-Suit shall remain in the Alkem Action (21-992) and shall be stayed until after the trial in the Consolidated Action. Ordered by Judge Christopher J. Burke on 9/21/2021. (dlb) |
| Sep 21, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. Nos. (14 in 1:21-cv-00992-JFB-CJB, 179 in 1:20-cv-01589-JFB-CJB) Stipulation Regarding Partial Consolidation and Partial Stay filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. Ordered by Judge Christopher J. Burke on 9/21/2021. Associated Cases: 1:21-cv-00992-JFB-CJB, 1:20-cv-01589-JFB-CJB(dlb) |
| Sep 20, 2021 | 15 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III and Timothy H. Kratz - filed by Alkem Laboratories Ltd.. Motions referred to Christopher J. Burke.(Dorsney, Kenneth) |
| Sep 17, 2021 | 14 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order Regarding Partial Consolidation and Partial Stay by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc.. (Silver, Daniel) |
| Sep 8, 2021 | 13 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME the deadline to submit (i) a copy Judge Burke's Case Management Checklist, (ii) a Proposed Scheduling Order, and (iii) a joint letter to September 17, 2021 - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) |
| Sep 8, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [13] STIPULATION TO EXTEND TIME the deadline to submit (i) a copy Judge Burke's Case Management Checklist, (ii) a Proposed Scheduling Order, and (iii) a joint letter to September 17, 2021 filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. Ordered by Judge Christopher J. Burke on 9/8/2021. (dlb) |
| Aug 20, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jason A. Leonard for Astellas Ireland Co., Ltd.,for Astellas Pharma Global Development, Inc.,for Astellas Pharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Aug 18, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [12] MOTION for Pro Hac Vice Appearance of Attorney Simon D. Roberts and Jason A. Leonard filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. Ordered by Judge Christopher J. Burke on 8/18/2021. (dlb) |
| Aug 17, 2021 | 12 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Simon D. Roberts and Jason A. Leonard - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # (1) Certifications for Simon D. Roberts and Jason A. Leonard)Motions referred to Christopher J. Burke.(Silver, Daniel) |
| Aug 17, 2021 | 12 | Certifications for Simon D. Roberts and Jason A. Leonard (2) |
| Aug 11, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the parties shall meet and confer and discuss, in person and/or by telephone, each of the matters listed on Judge Burke's Case Management Checklist (Checklist). Within thirty (30) days from the date of this Order, the parties shall jointly file the following: (i) a copy of the Checklist, indicating the names of Lead Counsel and Delaware Counsel for each party; (ii) a proposed Scheduling Order, which is consistent with Judge Burke/s "Rule 16 Scheduling Order - Patent" (and with additional changes made to accommodate the fact that this is an ANDA litigation matter); and (iii) a letter, not to exceed three pages, that contains the following: (a) a description of what this case is about; (b) the parties' positions regarding any disputes in the proposed Scheduling Order, and (c) a list of the three most significant topics (other than Scheduling Order disputes) discussed during the parties review of the Checklist items, along with a brief description as to what was discussed as to those topics. Thereafter, the Court may schedule a Case Management Conference/Rule 16 Scheduling Conference to be held with Judge Burke. The Checklist and Scheduling Order can be found on Judge Burke's portion of the District Court's website. Orderned by Judge Christopher J. Burke on 8/11/2021. (dlb) |
| Aug 11, 2021 | N/A | Remark re Newer Attorneys (0) Docket Text: REMARK: The parties should be aware that the Court encourages the participation of newer attorneys in courtroom proceedings and at oral argument. Please see the Court's Standing Order Regarding Courtroom Opportunities for Newer Attorneys, a link to which is provided here for the parties' convenience:http://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrder2017.pdf (dlb) |
| Aug 6, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER Pursuant to the filing of this case, the Court issues the following order: Magistrate Judge Christopher J. Burke shall issue a scheduling order when appropriate. Magistrate Judge Burke shall handle all nondispositive matters on all issues, except for Daubert motions, Markman hearings, and pretrial motions in limine. The parties have the right to file an appeal of the magistrate judge's order, and the same shall be decided by the undersigned. The magistrate judge shall likewise handle all discovery matters, scheduling, and pretrial conferences. If the parties believe the magistrate judge has a conflict of interest with this case, the parties shall so notify the Court. IT IS SO ORDERED. Signed by Judge Joseph F. Bataillon on 08/06/21. (AEV) |
| Jul 28, 2021 | 9 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Alkem Laboratories Ltd.. (Dorsney, Kenneth) |
| Jul 28, 2021 | 8 | Answer to Complaint (28) Docket Text: ANSWER to [1] Complaint, by Alkem Laboratories Ltd..(Dorsney, Kenneth) |
| Jul 19, 2021 | 7 | Exhibit A-B (6) |
| Jul 19, 2021 | 7 | Main Document (2) Docket Text: DECLARATION of Service on Alkem Laboratories Ltd. made on July 7, 2021 by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # (1) Exhibit A-B)(Joyce, Alexandra) |
| Jul 14, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Joseph F. Bataillon of the United States District Court for the District of Nebraska, due to prior related cases. Please include the initials of the Judge (JFB) after the case number on all documents filed. (rjb) |
| Jul 6, 2021 | 6 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (kmd) |
| Jul 6, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc. (kmd) |
| Jul 6, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,342,117; 7,982,049; 8,835,474; 10,842,780; RE44,872. (kmd) |
| Jul 6, 2021 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/25/2021. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 11/25/2023. (kmd) |
| Jul 6, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd) |
| Jul 6, 2021 | 1 | Civil Cover Sheet (2) |
| Jul 6, 2021 | 1 | Exhibit A - E (86) |
| Jul 6, 2021 | 1 | Main Document (22) Docket Text: COMPLAINT for Patent Infringement filed against Alkem Laboratories Ltd. - Magistrate Consent Notice to Pltf. (Filing fee $402, receipt number ADEDC-3651189.) - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc. (Attachments: # (1) Exhibit A - E, # (2) Civil Cover Sheet)(kmd) |
